AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 81 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2022. The put-call ratio across all filers is 1.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,599,283 | -36.7% | 1,902,843 | +1.3% | 0.23% | -37.3% |
| Q2 2023 | $30,971,573 | +79.9% | 1,879,343 | 0.0% | 0.37% | +56.8% |
| Q1 2023 | $17,214,782 | +292.1% | 1,879,343 | +206.5% | 0.23% | +296.6% |
| Q4 2022 | $4,390,090 | +805.2% | 613,141 | +532.7% | 0.06% | +742.9% |
| Q3 2022 | $485,000 | -87.5% | 96,906 | -93.9% | 0.01% | -88.3% |
| Q2 2022 | $3,868,000 | -73.2% | 1,585,292 | -25.1% | 0.06% | -74.5% |
| Q1 2022 | $14,452,000 | -21.0% | 2,116,029 | -6.5% | 0.24% | -10.3% |
| Q4 2021 | $18,285,000 | +8.0% | 2,263,002 | +31.0% | 0.26% | -5.1% |
| Q3 2021 | $16,925,000 | +981.5% | 1,727,060 | +642.7% | 0.28% | +851.7% |
| Q2 2021 | $1,565,000 | – | 232,537 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,625,000 | $12,269,000 | 3.04% |
| GENDELL JEFFREY L | 1,146,764 | $8,658,000 | 1.11% |
| Broadfin Capital, LLC | 1,029,012 | $7,769,000 | 1.04% |
| RTW INVESTMENTS, LP | 3,401,434 | $25,681,000 | 0.97% |
| BRANDES INVESTMENT PARTNERS, LP | 3,651,948 | $27,571,000 | 0.66% |
| Aristides Capital LLC | 71,520 | $540,000 | 0.42% |
| Tekla Capital Management LLC | 814,588 | $6,150,000 | 0.23% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 36,100 | $273,000 | 0.17% |
| Leap Investments LP | 43,481 | $328,000 | 0.15% |
| Brown Capital Management | 1,829,886 | $13,816,000 | 0.13% |